Philadelphia · Board & Non-Executive Director Search
Board & Non-Executive Director Search in Philadelphia, Pennsylvania
We run board and non-executive director searches for Philadelphia issuers, health systems and sponsor-backed platforms, filling the seats the region cannot fill locally: audit financial expert, cyber and technology risk, legal and compliance.
›Board search Philadelphia mandates fail in the independence screen, and close when the committee names one committee seat in week one.
Sartori & Partners is highly technical in Board & Non-Executive Director Search work in Philadelphia: 7 closed board searches over three years, 93% completion, a median of 4 to 7 months. Across 250 structured interviews with Philadelphia partners, general counsel and sitting directors, the constraint is not supply but eligibility, because the people who know the region's health systems and insurers are usually already paid by them. On a classified Pennsylvania board a director can be removed only for cause, so the screen carries the whole risk of the appointment.
01 — The brief answer
Board search Philadelphia: the file stalls in the screen, not in the sourcing
Philadelphia's board inventory is smaller than its economy suggests. Counting the headquarters cities Fortune published with its 2026 ranking, 11 Fortune 500 and 30 Fortune 1000 companies sit in the Philadelphia–Camden–Wilmington metro, and Universal Health Services runs a Fortune 255 board with 5 non-employee directors. Committees briefing us on board search Philadelphia work almost never fail on sourcing. They fail on the screen: from the ~7,500 lawyers we map in Philadelphia, the group that clears the audit-committee tests in 17 CFR 240.10A-3(b)(1) and still reads a Pennsylvania hospital system or a mortgage insurer without a tutorial is countable in an afternoon.
We have worked in the Philadelphia market for 8 years, for Nasdaq- and NYSE-listed issuers, Pennsylvania-chartered insurers, nonprofit health systems and sponsor-backed life-sciences platforms, across Healthcare & Life Sciences, Corporate & M&A, Litigation & Disputes and Bankruptcy & Restructuring. Over the last three years we closed 7 board searches at a 93% completion rate, with a median timeline of 4 to 7 months and 23 working days from seat offer to signed acceptance. The files that close name one committee seat in week one. The files that stall try to buy independence, sector fluency and financial-expert status in a single director. Pennsylvania makes that mistake expensive: on a classified board here, removal requires cause.
Years in this market
8years
Searches closed · 3 yrs
7
Completion rate
93%
Median timeline
4to 7 months
Sartori & Partners trailing record · Board & Non-Executive Director Search · Philadelphia
02 — The local market
Non-executive director search Philadelphia: who is actually eligible
Across 250 structured interviews with Philadelphia partners, general counsel and sitting directors between Q3 2024 and Q2 2026, Sartori's Philadelphia cohort put 62% of locally credible director candidates inside a relationship that fails an independence test: counsel to the issuer, a trustee at a health system that transacts with it, or an officer of a supplier. That is the Philadelphia problem in one number.
The region's director-credible pool concentrates in very few institutions. On the listed side, Comcast, Aramark, Lincoln Financial, Universal Health Services, Radian Group and FMC Corporation; on the nonprofit side, Penn Medicine, Jefferson Health, Children's Hospital of Philadelphia and Independence Blue Cross; on the professional side, the Am Law bar around Morgan Lewis, Dechert, Duane Morris, Ballard Spahr and Cozen O'Connor. A general counsel at a Pennsylvania-chartered insurer told us her committee struck 4 of 6 local names on affiliate grounds before anyone read a résumé. Sartori's Philadelphia mandate telemetry records 26 first-round director approaches across three audit-seat files over 18 months; 9 were declined before a first meeting, and 6 of those cited an existing nonprofit trusteeship as the reason.
03 — Selected engagements
Recent board & non-executive director search work in Philadelphia
Anonymised mandates from our Philadelphia book — profile, complication and outcome. Select an engagement to open its file.
PHILADELPHIA × BOARD & NON-EXECUTIVE DIRECTOR SEARCH3 ENGAGEMENTS · ANONYMISED
Audit financial expert for a Pennsylvania-chartered specialty insurer
A Pennsylvania-chartered specialty insurer, roughly $2.4bn market capitalization, NYSE-listed, with a 9-person classified board and 2 committee chairs retiring in the same year.
Mandate
Replace the retiring audit-committee chair with a director who meets the Item 407(d)(5) financial-expert definition and clears the affiliate and compensatory-fee tests against a dense book of regional reinsurance and brokerage relationships.
Complication
4 of the first 6 candidates held a trusteeship at a regional health system that bought coverage from the issuer, and a 5th had taken consulting fees inside the 3-year look-back, which left the local roster empty by week three.
Outcome
Seated a former divisional finance chief from a mid-Atlantic insurer outside the metro, with the $40,000 audit-chair fee agreed before the first interview; the committee dropped its Philadelphia residency preference in week five.
Cyber and technology risk seat at a mid-cap Philadelphia issuer
A Nasdaq-listed Philadelphia industrial, about $3.1bn market capitalization, 8 directors, no standing technology committee and a 3rd consecutive year of naming the audit committee as its cybersecurity owner.
Mandate
Add 1 director able to hold cybersecurity oversight in fact, not only in the disclosure, and to take the technology chair once a separate committee was chartered.
Complication
The committee declined to fund a 5th chair retainer, so the seat went to market on a $110,000 base against a $278,000 mid-cap median in total pay, and 2 finalists withdrew on the number.
Outcome
Seated a sitting divisional chief information officer from outside the region who took the seat with no chair fee, and the board chartered a technology committee at the following annual meeting.
Legal and compliance seat for a nonprofit health system board
A Philadelphia nonprofit health system with roughly 18,000 employees and a 22-member board, adding its 1st dedicated legal-and-compliance director.
Mandate
Find a director with False Claims Act, Stark and Anti-Kickback exposure who could chair a compliance committee without conflicting with the system's outside counsel panel.
Complication
The obvious names were partners at 3 firms already on that panel and the conflicts policy barred all of them, while 2 internal candidates stepped back once the term commitment was fixed at 3 years.
Outcome
Seated a former deputy legal chief of an out-of-state academic medical center, with a 2-year onboarding overlap alongside the retiring chair written into the charter.
04 — Mandates we run
Three Philadelphia board mandates: financial expert, cyber risk, legal and compliance
Three archetypes cover 6 of the 7 Philadelphia board searches we ran since 2023. The first is the audit financial expert seat: Item 407(d)(5) of Regulation S-K makes an issuer state that it has one or explain why it does not, and 17 CFR 240.10A-3(b)(2) puts appointment, compensation and oversight of the auditor on that same committee. The second is the technology and cyber-risk seat: Item 106(c) of Regulation S-K, in the Code of Federal Regulations text current in 2026, makes a registrant describe its board's oversight of cybersecurity threats and identify the committee that holds it. The third is the legal-and-compliance seat, briefed almost entirely by regulated employers: hospital systems, insurers and Pennsylvania-chartered banks.
Our Philadelphia files show where the three collide. On the metro's mid-cap boards the cyber mandate lands on the audit committee, which is already carrying the auditor and the financial-expert disclosure. A chief legal officer at a nonprofit health system described the result to us as “one committee doing three jobs”. Sartori's Philadelphia survey wave for Q1 2026 found 11 of 19 responding nominating committees had bolted cyber oversight onto an existing audit charter rather than charter a technology committee.
Hiring in Philadelphia?
We map this market every day.
The market intelligence on this page is the same coverage we use to run retained board & non-executive director search mandates in Philadelphia.
What a Philadelphia board seat pays, and where the national median misprices it
FW Cook's 2026 Director Compensation Report, published in August 2026 from proxies filed through 31 May 2026, puts median total director compensation at $330,000 for large-cap boards, $278,000 for mid-cap and $229,000 for small-cap, with an audit-chair retainer median of $20,000. Philadelphia's own filings sit on both sides of that line. Comcast's 2026 proxy shows a $120,000 cash retainer and an annual stock grant raised to $240,000 in October 2025, with nine non-employee directors between $375,016 and $415,016 for 2025. Radian Group paid a $140,000 retainer plus $160,000 in restricted stock units and a $40,000 audit-chair fee. Universal Health Services paid $100,000 in cash and $200,039 in units with a $25,000 audit chair; FMC Corporation paid $100,000 and $140,000 with a $20,000 audit chair.
Here the audit-chair premium tracks regulation, not market capitalization. A mortgage insurer pays its audit chair twice what a specialty chemicals board pays, on a fraction of the market value. A director who benchmarks on a national median therefore arrives underpriced at the regulated end and overpriced at the industrial end. Sartori's Philadelphia offer outcomes show that in 21 seat discussions over 24 months, 8 reopened on committee-chair fees rather than on the base retainer.
06 — Live market
Board composition and refreshment: how seats actually move in Philadelphia
Seats here move on three mechanics, and none of them is a vacancy notice. The first is contraction: FMC Corporation's 2026 proxy takes the board from 13 directors to 10 at the conclusion of the 2026 annual meeting, removing three seats from the metro's inventory in a single vote. The second is workload: Radian Group's board met 17 times in 2025 while the Inigo acquisition ran, and a board sitting 17 times a year is a different job from one sitting 6. The third is proxy-adviser pressure. The ISS United States benchmark policy, effective for meetings on or after 1 February 2026, recommends voting against a director who sits on more than five public company boards, and against a public-company chief executive who holds more than two outside seats, which caps how often one Philadelphia name can be recycled across local boards.
Pennsylvania then locks the outcome in place. A change to a company's removal provisions does not reach an incumbent director for the balance of the term for which he was selected, so a board that misjudges a seat waits out the class. Our Philadelphia mandate telemetry shows 2 of the 7 board files we ran since 2023 stalled past nine months, both after a committee reopened the specification at shortlist.
07 — Methodology
How we run a Philadelphia board mandate
01 — BriefMandate, success profile and conflicts frame agreed in writing.
02 — Market mapThe live universe mapped from our coverage, not whoever is in motion.
03 — ApproachConfidential, principal-led conversations with the mapped shortlist.
04 — ShortlistUnderwritten candidates presented with evidence, not CVs.
05 — OfferPackage design, references and counter-offer defence.
06 — CloseResignation, notice and the first hundred days, managed.
Median 4 to 7 months from signed brief to accepted offer on closed Philadelphia mandates.
A Philadelphia board mandate starts from the map, not from a call list. Sartori's research program covers nearly 1.5 million lawyer profiles worldwide and ~7,500 in Philadelphia, with quarterly market surveys running since 2019 and structured records for every mandate we close. Before a name is written down we run the eligibility arithmetic against public filings: the affiliate and compensatory-fee tests in 17 CFR 240.10A-3(b)(1), the financial-expert definition in Item 407(d)(5) of Regulation S-K, the cyber-oversight question in Item 106(c), and the Pennsylvania removal rule that decides how long the appointment lasts.
The screen is built to reject early. Across 250 structured interviews we put the same eligibility questions we will later put to a nominating committee, so an approach carries a cleared conflicts position before it is made. Our own limit shows up in every file: the research program reads law-firm partners and in-house lawyers well and reads career operators badly, a retired hospital chief financial officer or a plant president, so about a third of a Philadelphia financial-expert longlist is assembled from proxies and annual reports rather than from our map. Sartori's Philadelphia records put median offer-to-acceptance at 23 working days and counter-offer incidence at 9%.
Hiring in Philadelphia?
Brief us on the search.
Whether you are building a team or weighing a move, we listen first. No obligation.
Board & Non-Executive Director Search in Philadelphia — common questions
Who are the best board & non-executive director search in Philadelphia?
Nobody audits board & non-executive director search in Philadelphia, so a shortlist is better built from coverage, method and completed mandates than from any ranking. Sartori & Partners maps roughly 7,500 lawyers in Philadelphia and has worked this market for 8 years. Over the trailing three years we closed 7 board & non-executive director search searches here at a 93% completion rate, with a median timeline of 4 to 7 months. Across 250 structured interviews with Philadelphia partners, general counsel and sitting directors between Q3 2024 and Q2 2026, 62% of locally credible director candidates sat inside a relationship that fails an independence test. Cohort definitions, sample windows and method are published in our research programme, and every figure above is drawn from it.
How long does a board search Philadelphia mandate take, and what drives the variance?
Four to seven months is our Philadelphia median, with 23 working days from seat offer to signed acceptance. Audit financial expert seats run at the long end, because the affiliate and compensatory-fee tests in 17 CFR 240.10A-3(b)(1) remove most local candidates before an interview. A technology seat with a drafted charter can close in 5 months. Where a board is classified, the seating date is set by the class whose term expires next, not by the acceptance date.
Which committee seat is hardest to fill on a Philadelphia board?
The audit financial expert seat, by a distance: it is the one Item 407(d)(5) of Regulation S-K makes an issuer either claim or explain away. Two things make it harder here than the national picture suggests. The audit committee is also the committee that appoints and oversees the auditor under 17 CFR 240.10A-3(b)(2), and on the metro's mid-cap boards it has usually absorbed cybersecurity oversight as well. Sartori's Philadelphia survey wave for Q1 2026 found 11 of 19 responding committees in exactly that position.
What does Pennsylvania law change about a board appointment here?
On a classified Pennsylvania board a director can be removed only for cause, so the screen carries the whole risk of the appointment. Under 15 Pa.C.S. section 1726, a later change to the removal provisions does not reach an incumbent director for the balance of the term for which he was selected. The practical effect on a search is that a Philadelphia committee will spend four to six weeks on eligibility before it will look at a longlist, and that time is not lost time.
What does a non-executive director seat pay in Philadelphia?
Between $255,000 and $375,000 in total annual compensation at the metro's larger listed boards for 2025, against an FW Cook large-cap median of $330,000 in its 2026 report. Committee-chair fees are where the local spread opens: Radian Group pays a $40,000 audit-chair retainer, Universal Health Services $25,000 and FMC Corporation $20,000. Regulated issuers pay the premium, not the largest ones. Sartori's Philadelphia offer outcomes show that in 21 seat discussions over 24 months, 8 reopened on chair fees rather than on the base retainer.
How do you clear an independence problem before the first interview?
We run the affiliate and compensatory-fee tests in 17 CFR 240.10A-3(b)(1) against a candidate's trusteeships and consulting income before any approach is made. In Philadelphia that means checking nonprofit health-system and university trusteeships first, because those are the relationships that transact with the issuer. Sartori's Philadelphia mandate telemetry records 26 first-round approaches across three audit-seat files over 18 months, of which 9 declined before a first meeting; 6 named a nonprofit trusteeship as the reason.
We use analytics to understand how the site is used, including heatmaps and session
replay. No advertising cookies. See our
Cookie Policy and Privacy Policy.
